LMNT reports that GLP-1 medications for obesity and diabetes may lead to electrolyte imbalances, highlighting hydration ...

How weight-loss jabs are changing the way we spend money - Around 2.5 million people are currently estimated to be on ...

Joe Pyfer is ready for the biggest fight of his career against the former two-time middleweight champ at UFC Seattle. Kate ...

Joe Pyfer is ready for the biggest fight of his career against the former two-time middleweight champ at UFC Seattle. The ...

A year after his legal battle with Bridgeport ended, Amit Lakhotia said he is focusing on residential developments in New Britain.

Heineken, Chubb, and India stocks are in our panelists’ sights this year. How to assemble your own sports portfolio.

While the medications may be pricey, a multi-year study by Aon found consistent use correlates with lower medical cost growth ...

The weight loss drug boom could drive fuel costs down.

The popularity of GLP-1 weight-loss drugs has seen a seismic shift in just over a year. Not long ago, they were primarily used for diabetes. But now, that’s changing. In some markets, such as the US, ...

GLP-1 medications have dominated the weight-loss landscape this year — but some older Americans are reportedly kicking the trend to the curb. A study published in JAMA in January 2025 — which looked ...

GLP-1 weight-loss drugs are more popular than ever. With their ability to increase feelings of fullness and make people eat less, they could not only reshape global food markets but the way people eat ...

A good night's sleep might be an additional benefit some gain from taking weight-loss drugs like Ozempic and Zepbound, a new study says. Obese patients with type 2 diabetes are less likely to need a ...